Roles in Cancer Biological Processes and Potential Clinical Value

Total Page:16

File Type:pdf, Size:1020Kb

Roles in Cancer Biological Processes and Potential Clinical Value Cancer Biol Med 2020. doi: 10.20892/j.issn.2095-3941.2020.0032 REVIEW CMTM family proteins 1–8: roles in cancer biological processes and potential clinical value Jie Wu*, Lan Li*, Siyi Wu, Bin Xu Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, China ABSTRACT The CKLF-like MARVEL transmembrane domain containing (CMTM) family of genes comprises CKLF and CMTM1–8 (previously called chemokine-like factor superfamily 1–8, CKLFSF1–8). The CMTM family proteins contain a structurally conserved MAL and related proteins for vesicle trafficking and membrane linking (MARVEL) domain. Dysregulated expression of multiple CMTM family members is a common feature in many human cancer types. CMTM proteins control critical biological processes in cancer development, including growth factor receptor activation and recycling, cell proliferation, apoptosis, metastasis, and immune evasion. Emerging in vivo and in vitro evidence indicates that the mechanisms of action of most CMTM proteins are complex and multifactorial. This review highlights new findings regarding the roles of CMTM1–8 in cancer, particularly in tumor growth, metastasis, and immune evasion. Additionally, the potential clinical value of CMTMs as novel drug targets or biomarkers is discussed. KEYWORDS CMTM family; cancer; cell cycle; EGFR; EMT; apoptosis; tumor immunity Introduction CMTM genes have been reported to be differentially expressed between tumor and normal tissue, thus suggesting Cancer is a highly heterogeneous group of diseases and one that CMTMs may actively regulate tumor development in of the leading causes of death worldwide. Each tumor type various cancer types4-10. The functions of CMTM family pro- exhibits distinct biological characteristics, clinical features, teins in tumor growth, metastasis, and antitumor immunity outcomes, and responses to therapies. Although the mecha- are well recognized11-14. In addition, CMTM family proteins nisms involved in cancer development have been extensively play crucial roles in mediating the clinical characteristics of studied, much remains to be learned about cancer-associated tumors, including promoting chemotherapeutic resistance in biological regulation. The CKLF-like MARVEL transmem- non-small cell lung cancer (NSCLC)15, and have prognostic brane domain containing (CMTM) family of genes comprises value in multiple cancers15-18. In this review, we focus on the CKLF and CMTM1–8, and their encoded proteins are struc- CMTM family’s biological effects in tumors and potential clin- turally characterized as similar to chemokines and members ical applications. of the transmembrane-4 superfamily (TM4SF). The CMTM family was first cloned and reported in 20011. To date, CMTM Structural characteristics of CMTM family members have been revealed to function as regulators family gene transcripts and proteins in various diseases, including autoimmune2 and cardiovascu- lar diseases3. Moreover, recent in-depth studies have indicated CMTM1–8 were first identified in 2003 through analysis com- that CMTMs also play crucial roles in cancer-associated bio- bining CKLF2 cDNA and protein sequence analysis with exper- logical regulation. imental validation19. CMTM1 contains a C-c motif and exhib- its higher sequence identity with chemokines than do other *These authors contributed equally to this work. Correspondence to: Bin Xu CMTMs. CMTM8 has the lowest sequence identity with chemok- 19 E-mail: [email protected] ines but has 39.3% amino acid similarity with TM4SF11 , and ORCID ID: https://orcid.org/0000-0002-0499-0430 the level of sequence identity between CMTM2–7 and chemok- Received January 30, 2020; accepted June 8, 2020. ines is intermediate between those of CMTM1 and CMTM819. Available at www.cancerbiomed.org ©2020 Cancer Biology & Medicine. Creative Commons Thus, proteins encoded by CMTM1–8 have a common feature Attribution-NonCommercial 4.0 International License of structural similarity with classical chemokines and TM4SF. Cancer Biol Med Vol 17, No 3 August 2020 529 Most CMTM transcripts have multiple alternative splicing of individual CMTM family members in biological processes forms, but all the resulting protein products contain a MAL and may depend on the specific alternative splicing isoforms of each related proteins for vesicle trafficking and membrane linking transcript21,22,23. The genes in the CMTM family form 2 gene (MARVEL) domain19. Therefore, these proteins were renamed clusters. The CMTM1–4 genes form a gene cluster on chromo- CMTM1–8, or CKLF-like MARVEL transmembrane domain some 16, whereas CMTM6–8 form the second gene cluster on containing 1–8, whereas they were previously called chemok- chromosome 3p22.3 (Table 1, Figure 1), where many critical ine-like factor superfamily 1–8 (CKLFSF1–8)20. The functions tumor suppressor genes are located. Table 1 Characteristics of CMTM family members Gene Location Main subcellular locations Gene ontology (GO) - biological process CMTM1 16q21 Plasma membrane, extracellular space, Chemotaxis, regulation of signaling receptor activity nucleus, peroxisome CMTM2 16q21 Nucleus, plasma membrane, extracellular Chemotaxis, regulation of signaling receptor activity space, Golgi apparatus, peroxisome, cytosol CMTM3 16q22.1 Plasma membrane, extracellular space, Chemotaxis, regulation of signaling receptor activity, positive regulation of nucleus, endosome B cell receptor signaling pathway CMTM4 16q22.1 Plasma membrane, extracellular space, Chemotaxis, regulation of signaling receptor activity nucleus, Golgi apparatus CMTM5 14q11.2 Plasma membrane, extracellular space Chemotaxis, regulation of signaling receptor activity, negative regulation of myoblast differentiation CMTM6 3p22.3 Plasma membrane, extracellular space, Chemotaxis, regulation of signaling receptor activity, neutrophil degranulation lysosome, cytoskeleton, cytosol, endosome CMTM7 3p22.3 Plasma membrane, extracellular space B-1a B cell differentiation, chemotaxis, regulation of signaling receptor activity CMTM8 3p22.3 Nucleus, plasma membrane and Membrane raft polarization, chemotaxis, protein localization, regulation of extracellular space signaling receptor activity, myelination The information is available in the Gene Cards database: https://www.genecards.org/. Chromosome 16 Chromosome 14 971 bp 167 bp 161 bp 175 bp 90 bp 176 bp 3357 bp 971 bp 353 bp 2602 bp CMTM1 819 bp 153 bp 201 bp 93 bp 85 bp 299 bp CMTM5 123 4 5 6 311 bp 246 bp 222 bp 156 bp 96 bp 121 bp 1284 bp 12 3 4 5 6 CMTM2 CMTM5-v1 124 5 6 15.75 kb CMTM3-v1 123 4 5 6 CMTM5-v2 1 2 3 4 5 6 CMTM3 Chromosome 3 870 bp CMTM8 1.2 kb 12.9 kb 59.7 kb CMTM4 1.2 kb 12.9 kb 59.7 kb 21.35 kb 147 bp 174 bp 117 bp 84 bp 7473 bp 99 bp 177 bp 368 bp 1 2 3 4 4C 4B 4A 3 2 1 CMTM7 26.47 kb CMTM4-v1 4C 4A 3 2 1 CMTM8-v1 1 2 3 4 CMTM8-v2 1 3 4 CMTM4-v2 4C 4B 4A 32 1 CMTM6 : Exon : Intron Figure 1 Chromosome locations and genomic structures of the human CMTMs (modified from references 9, 19, 20, 24, and 25). The sche- matic maps and major splice forms of human CMTM3–CMTM5 and CMTM8 are presented. 530 Wu et al. CMTM family proteins 1–8 in cancer Expression of CMTM family in normal adult and fetal tissues but show decreased expres- members sion with frequent DNA methylation in the promoter regions in most carcinoma cell lines9,29. CMTM6 has been shown to be upregulated in the tissues of some tumors, including gli- The CMTM1–CMTM4 genes are highly expressed in the male omas17,12,30. The pan-cancer expression of CMTM family reproductive system (testis) and compartments in the immune genes and their prognostic value in The Cancer Genome Atlas system, including the bone marrow and peripheral blood cells, (TCGA) database are summarized in Figure 2. such as resting CD19+ cells and activated peripheral blood Many biological processes and molecules, such as DNA monocytes20,26,27. The CMTM3 and CMTM5 genes, as well methylation and microRNAs (Figure 3A), regulate the as the CMTM7 and CMTM8 genes18,28, are broadly expressed expression of CMTM family members. The CMTM3 gene 1 2 3 4 5 6 7 8 A CMTM 1CMTM 2 CMTM 3CMTM 4 CMTM 5 CMTM 6CMTM 7 CMTM 8 B CMTM CMTM CMTM CMTM CMTM CMTM CMTM CMTM l l ACC (n = 79) P ≥ 0.05 BLCA (n = 408) BRCA (n = 1100) Normal Normal Norma Normal Normal Norma Normal Normal Tumor Tumor Tumor Tumor Tumor Tumor Tumor Tumor P < 0.05 BRCA−Basal (n = 191) BLCA 6 BRCA−Her2 (n = 82) BRCA−LumA (n = 568) Z-score BRCA BRCA−LumB (n = 219) 7.2 CESC 5 CESC (n = 306) CHOL (n = 36) CHOL 4 COAD (n = 458) COAD DLBC (n = 48) ESCA (n = 185) ESCA GBM (n = 153) 0.0 3 HNSC (n = 522) HNSC HNSC−HPV− (n = 422) KICH HNSC−HPV+ (n = 98) 2 KICH (n = 66) −6.1 KIRC KIRC (n = 533) KIRP (n = 290) s 1 KIRP LAML (n = 173) LIHC LGG (n = 516) 0 LIHC (n = 371) LUAD LUAD (n = 515) LUSC (n = 501) LUSC MESO (n = 87) Cancer type PAAD OV (n = 303) PAAD (n = 179) PCPG PCPG (n = 181) PRAD PRAD (n = 498) READ (n = 166) READ SARC (n = 260) SKCM (n = 471) SARC SKCM−Metastasis (n = 368) SKCM SKCM−Primary (n = 103) STAD (n = 415) STAD TGCT (n = 150) THCA (n = 509) THCA THYM (n = 120) THYM UCEC (n = 545) UCS (n = 57) UCEC UVM (n = 80) Log (TPM + 1) Figure 2 Pan-cancer expression of CMTMs and their prognostic value in TCGA. (A) Expression matrix plots showing gene expression of CMTMs in different cancers. The results were derived from the Gene Expression Profiling Interactive Analysis (GEPIA) database. The density of the color in each block represents the median expression value of a gene in a given tissue, normalized by the maximum median expression value across all blocks. (B) The prognostic value of CMTM gene expression. The results were derived from the Tumor Immune Estimation Resource (TIMER) database. The univariate Cox proportional hazard model was used to evaluate the significance of gene expression outcomes (the gene expression was treated as continuous variable).
Recommended publications
  • SPATA33 Localizes Calcineurin to the Mitochondria and Regulates Sperm Motility in Mice
    SPATA33 localizes calcineurin to the mitochondria and regulates sperm motility in mice Haruhiko Miyataa, Seiya Ouraa,b, Akane Morohoshia,c, Keisuke Shimadaa, Daisuke Mashikoa,1, Yuki Oyamaa,b, Yuki Kanedaa,b, Takafumi Matsumuraa,2, Ferheen Abbasia,3, and Masahito Ikawaa,b,c,d,4 aResearch Institute for Microbial Diseases, Osaka University, Osaka 5650871, Japan; bGraduate School of Pharmaceutical Sciences, Osaka University, Osaka 5650871, Japan; cGraduate School of Medicine, Osaka University, Osaka 5650871, Japan; and dThe Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan Edited by Mariana F. Wolfner, Cornell University, Ithaca, NY, and approved July 27, 2021 (received for review April 8, 2021) Calcineurin is a calcium-dependent phosphatase that plays roles in calcineurin can be a target for reversible and rapidly acting male a variety of biological processes including immune responses. In sper- contraceptives (5). However, it is challenging to develop molecules matozoa, there is a testis-enriched calcineurin composed of PPP3CC and that specifically inhibit sperm calcineurin and not somatic calci- PPP3R2 (sperm calcineurin) that is essential for sperm motility and male neurin because of sequence similarities (82% amino acid identity fertility. Because sperm calcineurin has been proposed as a target for between human PPP3CA and PPP3CC and 85% amino acid reversible male contraceptives, identifying proteins that interact with identity between human PPP3R1 and PPP3R2). Therefore, identi- sperm calcineurin widens the choice for developing specific inhibitors. fying proteins that interact with sperm calcineurin widens the choice Here, by screening the calcineurin-interacting PxIxIT consensus motif of inhibitors that target the sperm calcineurin pathway. in silico and analyzing the function of candidate proteins through the The PxIxIT motif is a conserved sequence found in generation of gene-modified mice, we discovered that SPATA33 inter- calcineurin-binding proteins (8, 9).
    [Show full text]
  • Genetic and Genomic Analysis of Hyperlipidemia, Obesity and Diabetes Using (C57BL/6J × TALLYHO/Jngj) F2 Mice
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Nutrition Publications and Other Works Nutrition 12-19-2010 Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6J × TALLYHO/JngJ) F2 mice Taryn P. Stewart Marshall University Hyoung Y. Kim University of Tennessee - Knoxville, [email protected] Arnold M. Saxton University of Tennessee - Knoxville, [email protected] Jung H. Kim Marshall University Follow this and additional works at: https://trace.tennessee.edu/utk_nutrpubs Part of the Animal Sciences Commons, and the Nutrition Commons Recommended Citation BMC Genomics 2010, 11:713 doi:10.1186/1471-2164-11-713 This Article is brought to you for free and open access by the Nutrition at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Nutrition Publications and Other Works by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. Stewart et al. BMC Genomics 2010, 11:713 http://www.biomedcentral.com/1471-2164/11/713 RESEARCH ARTICLE Open Access Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6J × TALLYHO/JngJ) F2 mice Taryn P Stewart1, Hyoung Yon Kim2, Arnold M Saxton3, Jung Han Kim1* Abstract Background: Type 2 diabetes (T2D) is the most common form of diabetes in humans and is closely associated with dyslipidemia and obesity that magnifies the mortality and morbidity related to T2D. The genetic contribution to human T2D and related metabolic disorders is evident, and mostly follows polygenic inheritance. The TALLYHO/ JngJ (TH) mice are a polygenic model for T2D characterized by obesity, hyperinsulinemia, impaired glucose uptake and tolerance, hyperlipidemia, and hyperglycemia.
    [Show full text]
  • Genome-Wide DNA Methylation Analysis of KRAS Mutant Cell Lines Ben Yi Tew1,5, Joel K
    www.nature.com/scientificreports OPEN Genome-wide DNA methylation analysis of KRAS mutant cell lines Ben Yi Tew1,5, Joel K. Durand2,5, Kirsten L. Bryant2, Tikvah K. Hayes2, Sen Peng3, Nhan L. Tran4, Gerald C. Gooden1, David N. Buckley1, Channing J. Der2, Albert S. Baldwin2 ✉ & Bodour Salhia1 ✉ Oncogenic RAS mutations are associated with DNA methylation changes that alter gene expression to drive cancer. Recent studies suggest that DNA methylation changes may be stochastic in nature, while other groups propose distinct signaling pathways responsible for aberrant methylation. Better understanding of DNA methylation events associated with oncogenic KRAS expression could enhance therapeutic approaches. Here we analyzed the basal CpG methylation of 11 KRAS-mutant and dependent pancreatic cancer cell lines and observed strikingly similar methylation patterns. KRAS knockdown resulted in unique methylation changes with limited overlap between each cell line. In KRAS-mutant Pa16C pancreatic cancer cells, while KRAS knockdown resulted in over 8,000 diferentially methylated (DM) CpGs, treatment with the ERK1/2-selective inhibitor SCH772984 showed less than 40 DM CpGs, suggesting that ERK is not a broadly active driver of KRAS-associated DNA methylation. KRAS G12V overexpression in an isogenic lung model reveals >50,600 DM CpGs compared to non-transformed controls. In lung and pancreatic cells, gene ontology analyses of DM promoters show an enrichment for genes involved in diferentiation and development. Taken all together, KRAS-mediated DNA methylation are stochastic and independent of canonical downstream efector signaling. These epigenetically altered genes associated with KRAS expression could represent potential therapeutic targets in KRAS-driven cancer. Activating KRAS mutations can be found in nearly 25 percent of all cancers1.
    [Show full text]
  • Supplemental Information
    Supplemental information Dissection of the genomic structure of the miR-183/96/182 gene. Previously, we showed that the miR-183/96/182 cluster is an intergenic miRNA cluster, located in a ~60-kb interval between the genes encoding nuclear respiratory factor-1 (Nrf1) and ubiquitin-conjugating enzyme E2H (Ube2h) on mouse chr6qA3.3 (1). To start to uncover the genomic structure of the miR- 183/96/182 gene, we first studied genomic features around miR-183/96/182 in the UCSC genome browser (http://genome.UCSC.edu/), and identified two CpG islands 3.4-6.5 kb 5’ of pre-miR-183, the most 5’ miRNA of the cluster (Fig. 1A; Fig. S1 and Seq. S1). A cDNA clone, AK044220, located at 3.2-4.6 kb 5’ to pre-miR-183, encompasses the second CpG island (Fig. 1A; Fig. S1). We hypothesized that this cDNA clone was derived from 5’ exon(s) of the primary transcript of the miR-183/96/182 gene, as CpG islands are often associated with promoters (2). Supporting this hypothesis, multiple expressed sequences detected by gene-trap clones, including clone D016D06 (3, 4), were co-localized with the cDNA clone AK044220 (Fig. 1A; Fig. S1). Clone D016D06, deposited by the German GeneTrap Consortium (GGTC) (http://tikus.gsf.de) (3, 4), was derived from insertion of a retroviral construct, rFlpROSAβgeo in 129S2 ES cells (Fig. 1A and C). The rFlpROSAβgeo construct carries a promoterless reporter gene, the β−geo cassette - an in-frame fusion of the β-galactosidase and neomycin resistance (Neor) gene (5), with a splicing acceptor (SA) immediately upstream, and a polyA signal downstream of the β−geo cassette (Fig.
    [Show full text]
  • Análise Integrativa De Perfis Transcricionais De Pacientes Com
    UNIVERSIDADE DE SÃO PAULO FACULDADE DE MEDICINA DE RIBEIRÃO PRETO PROGRAMA DE PÓS-GRADUAÇÃO EM GENÉTICA ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas Ribeirão Preto – 2012 ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas Tese apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo para obtenção do título de Doutor em Ciências. Área de Concentração: Genética Orientador: Prof. Dr. Eduardo Antonio Donadi Co-orientador: Prof. Dr. Geraldo A. S. Passos Ribeirão Preto – 2012 AUTORIZO A REPRODUÇÃO E DIVULGAÇÃO TOTAL OU PARCIAL DESTE TRABALHO, POR QUALQUER MEIO CONVENCIONAL OU ELETRÔNICO, PARA FINS DE ESTUDO E PESQUISA, DESDE QUE CITADA A FONTE. FICHA CATALOGRÁFICA Evangelista, Adriane Feijó Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas. Ribeirão Preto, 2012 192p. Tese de Doutorado apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo. Área de Concentração: Genética. Orientador: Donadi, Eduardo Antonio Co-orientador: Passos, Geraldo A. 1. Expressão gênica – microarrays 2. Análise bioinformática por module maps 3. Diabetes mellitus tipo 1 4. Diabetes mellitus tipo 2 5. Diabetes mellitus gestacional FOLHA DE APROVAÇÃO ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas.
    [Show full text]
  • Role of RUNX1 in Aberrant Retinal Angiogenesis Jonathan D
    Page 1 of 25 Diabetes Identification of RUNX1 as a mediator of aberrant retinal angiogenesis Short Title: Role of RUNX1 in aberrant retinal angiogenesis Jonathan D. Lam,†1 Daniel J. Oh,†1 Lindsay L. Wong,1 Dhanesh Amarnani,1 Cindy Park- Windhol,1 Angie V. Sanchez,1 Jonathan Cardona-Velez,1,2 Declan McGuone,3 Anat O. Stemmer- Rachamimov,3 Dean Eliott,4 Diane R. Bielenberg,5 Tave van Zyl,4 Lishuang Shen,1 Xiaowu Gai,6 Patricia A. D’Amore*,1,7 Leo A. Kim*,1,4 Joseph F. Arboleda-Velasquez*1 Author affiliations: 1Schepens Eye Research Institute/Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, 20 Staniford St., Boston, MA 02114 2Universidad Pontificia Bolivariana, Medellin, Colombia, #68- a, Cq. 1 #68305, Medellín, Antioquia, Colombia 3C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 4Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, 243 Charles St., Boston, MA 02114 5Vascular Biology Program, Boston Children’s Hospital, Department of Surgery, Harvard Medical School, 300 Longwood Ave., Boston, MA 02115 6Center for Personalized Medicine, Children’s Hospital Los Angeles, Los Angeles, 4650 Sunset Blvd, Los Angeles, CA 90027, USA 7Department of Pathology, Harvard Medical School, 25 Shattuck St., Boston, MA 02115 Corresponding authors: Joseph F. Arboleda-Velasquez: [email protected] Ph: (617) 912-2517 Leo Kim: [email protected] Ph: (617) 912-2562 Patricia D’Amore: [email protected] Ph: (617) 912-2559 Fax: (617) 912-0128 20 Staniford St. Boston MA, 02114 † These authors contributed equally to this manuscript Word Count: 1905 Tables and Figures: 4 Diabetes Publish Ahead of Print, published online April 11, 2017 Diabetes Page 2 of 25 Abstract Proliferative diabetic retinopathy (PDR) is a common cause of blindness in the developed world’s working adult population, and affects those with type 1 and type 2 diabetes mellitus.
    [Show full text]
  • Detection of Genetic Variations of Five MMAF-Related Genes and Their
    Detection of genetic variations of ve MMAF-related genes and their associations with litter size in goat Zhen Wang Northwest Agriculture and Forestry University Yun Pan Northwest Agriculture and Forestry University Libang He Northwest Agriculture and Forestry University Hong Chen Northwest Agriculture and Forestry University Chuanying Pan Northwest Agriculture and Forestry University Lei Qu Yulin University Xiaoyue Song Yulin University Xianyong Lan ( [email protected] ) https://orcid.org/0000-0003-2254-5805 Research article Keywords: goats; insertion/deletion (indel); MMAF; DNAH1; litter sizes; correlation analysis Posted Date: September 12th, 2019 DOI: https://doi.org/10.21203/rs.2.14419/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/13 Abstract Background: Multiple morphological abnormalities of the sperm agella (MMAF) makes an assignable contribution to male infertility, including QRICH2 , CFAP43 , CFAP44 , CFAP69 , CCDC39 , AKAP4 and DNAH1 gene. This work studied 28 putative indel mutations of MMAF related genes including QRICH2 , CFAP69 , CFAP43 , CCDC39 and DNAH1 gene and their correlation with the rst-born litter sizes of 769 Shaanbei white cashmere (SBWC) goats. Results: Electrophoresis and DNA sequencing analysis showed the 11-bp indel within QRICH2 ( QRICH2 -P4), the three indel variations in CFAP69 ( CFAP69 -P4, CFAP69 - P6 and CFAP69 -P7) and the 27-bp indel of DNAH1 ( DNAH1 -P1) were found to be polymorphic. The 27- bp indel variation within DNAH1 was not in consistent with HWE and the other four indel of QRICH2 and CFAP69 were in consistent with HWE. The linkage disequilibrium (LD) analysis showed the 8-bp indel ( CFAP69 -P4) and the 6-bp indel ( CFAP69- P6) within CFAP69 were in complete LD with each other (D'=0.99, r 2 =1.00).
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • Supplementary Figures and Tables
    SUPPLEMENTARY DATA Supplementary Figure 1. Isolation and culture of endothelial cells from surgical specimens of FVM. (A) Representative pre-surgical fundus photograph of a right eye exhibiting a FVM encroaching on the optic nerve (dashed line) causing tractional retinal detachment with blot hemorrhages throughout retina (arrow heads). (B) Magnetic beads (arrows) allow for separation and culturing of enriched cell populations from surgical specimens (scale bar = 100 μm). (C) Cultures of isolated cells stained positively for CD31 representing a successfully isolated enriched population (scale bar = 40 μm). ©2017 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1035/-/DC1 SUPPLEMENTARY DATA Supplementary Figure 2. Efficient siRNA knockdown of RUNX1 expression and function demonstrated by qRT-PCR, Western Blot, and scratch assay. (A) RUNX1 siRNA induced a 60% reduction of RUNX1 expression measured by qRT-PCR 48 hrs post-transfection whereas expression of RUNX2 and RUNX3, the two other mammalian RUNX orthologues, showed no significant changes, indicating specificity of our siRNA. Functional inhibition of Runx1 signaling was demonstrated by a 330% increase in insulin-like growth factor binding protein-3 (IGFBP3) RNA expression level, a known target of RUNX1 inhibition. Western blot demonstrated similar reduction in protein levels. (B) siRNA- 2’s effect on RUNX1 was validated by qRT-PCR and western blot, demonstrating a similar reduction in both RNA and protein. Scratch assay demonstrates functional inhibition of RUNX1 by siRNA-2. ns: not significant, * p < 0.05, *** p < 0.001 ©2017 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1035/-/DC1 SUPPLEMENTARY DATA Supplementary Table 1.
    [Show full text]
  • Identification of Eight Genes Encoding Chemokine-Like
    中国科技论文在线 http://www.paper.edu.cn Genomics 81 (2003) 609–617 Identification of eight genes encoding chemokine-like factor superfamily members 1–8 (CKLFSF1–8) by in silico cloning and experimental validation૾ Wenling Han,1 Peiguo Ding,1 Mingxu Xu, Lu Wang, Min Rui, Shuang Shi, Yanan Liu, Ying Zheng, Yingyu Chen, Tian Yang, and Dalong Ma* Center for Human Disease Genomics, Peking University, 38 Xueyuan Road, Beijing 100083, China Received 21 November 2002; accepted 14 March 2003 Abstract TM4SF11 is only 102 kb from the chemokine gene cluster composed of SCYA22, SCYD1, and SCYA17 on chromosome 16q13. CKLF maps on chromosome 16q22. CKLFs have some characteristics associated with the CCL22/MDC, CX3CL1/fractalkine, CCL17/TARC, and TM4SF proteins. Bioinformatics based on CKLF2 cDNA and protein sequences in combination with experimental validation identified eight novel genes designated chemokine-like factor superfamily members 1–8 (CKLFSF1–8). CKLFSF1–8 form gene clusters; the sequence identities between CKLF2 and CKLFSF1–8 are from 12.5 to 39.7%. Most of the CKLFSFs have alternative RNA splicing forms. CKLFSF1 has a CC motif and higher sequence similarity with chemokines than with any of the other CKLFSFs. CKLFSF8 shares 39.3% amino acid identity with TM4SF11. CKLFSF1 links the CKLFSF family with chemokines, and CKLFSF8 links it with TM4SF. The characteristics of CKLFSF2–7 are intermediate between CKLFSF1 and CKLFSF8. This indicates that CKLFSF represents a novel gene family between the SCY and the TM4SF gene families. © 2003 Elsevier Science (USA). All rights reserved. Keywords: CKLF; CKLFSF; Bioinformatics; Gene cluster; Chemokine; TM4SF11 Chemokines are small, secreted proteins that can be CXC chemokines (CXCL1–16), 2 C chemokines (XCL1– subdivided according to their NH2-terminal cysteine-motif 2), and one CX3C chemokine (CX3CL1/fractalkine) iden- into the CC, CXC, C, and CX3C classes.
    [Show full text]
  • MOCHI Enables Discovery of Heterogeneous Interactome Modules in 3D Nucleome
    Downloaded from genome.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press MOCHI enables discovery of heterogeneous interactome modules in 3D nucleome Dechao Tian1,# , Ruochi Zhang1,# , Yang Zhang1, Xiaopeng Zhu1, and Jian Ma1,* 1Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213, USA #These two authors contributed equally *Correspondence: [email protected] Contact To whom correspondence should be addressed: Jian Ma School of Computer Science Carnegie Mellon University 7705 Gates-Hillman Complex 5000 Forbes Avenue Pittsburgh, PA 15213 Phone: +1 (412) 268-2776 Email: [email protected] 1 Downloaded from genome.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract The composition of the cell nucleus is highly heterogeneous, with different constituents forming complex interactomes. However, the global patterns of these interwoven heterogeneous interactomes remain poorly understood. Here we focus on two different interactomes, chromatin interaction network and gene regulatory network, as a proof-of-principle, to identify heterogeneous interactome modules (HIMs), each of which represents a cluster of gene loci that are in spatial contact more frequently than expected and that are regulated by the same group of transcription factors. HIM integrates transcription factor binding and 3D genome structure to reflect “transcriptional niche” in the nucleus. We develop a new algorithm MOCHI to facilitate the discovery of HIMs based on network motif clustering in heterogeneous interactomes. By applying MOCHI to five different cell types, we found that HIMs have strong spatial preference within the nucleus and exhibit distinct functional properties. Through integrative analysis, this work demonstrates the utility of MOCHI to identify HIMs, which may provide new perspectives on the interplay between transcriptional regulation and 3D genome organization.
    [Show full text]
  • Article Reference
    Article Comprehensive evaluation of coding region point mutations in microsatellite‐unstable colorectal cancer KONDELIN, Johanna, et al. Reference KONDELIN, Johanna, et al. Comprehensive evaluation of coding region point mutations in microsatellite‐unstable colorectal cancer. EMBO Molecular Medicine, 2018, vol. 10, no. 9, p. e8552 PMID : 30108113 DOI : 10.15252/emmm.201708552 Available at: http://archive-ouverte.unige.ch/unige:120174 Disclaimer: layout of this document may differ from the published version. 1 / 1 Published online: August 14, 2018 Report Comprehensive evaluation of coding region point mutations in microsatellite-unstable colorectal cancer Johanna Kondelin1,2, Kari Salokas3,4, Lilli Saarinen2, Kristian Ovaska2, Heli Rauanheimo1,2, Roosa-Maria Plaketti1,2, Jiri Hamberg1,2, Xiaonan Liu3,4 , Leena Yadav3,4, Alexandra E Gylfe1,2, Tatiana Cajuso1,2, Ulrika A Hänninen1,2, Kimmo Palin1,2, Heikki Ristolainen1,2, Riku Katainen1,2, Eevi Kaasinen1,2, Tomas Tanskanen1,2, Mervi Aavikko1,2, Minna Taipale5, Jussi Taipale1,2,6,7 , Laura Renkonen-Sinisalo8, Anna Lepistö8, Selja Koskensalo9, Jan Böhm10, Jukka-Pekka Mecklin11,12, Halit Ongen13,14,15, Emmanouil T Dermitzakis13,14,15, Outi Kilpivaara1,2, Pia Vahteristo1,2, Mikko Turunen2, Sampsa Hautaniemi2, Sari Tuupanen1,2, Auli Karhu1,2, Niko Välimäki1,2, Markku Varjosalo3,4, Esa Pitkänen1,2 & Lauri A Aaltonen1,2,* Abstract not been linked to CRC before. Two genes, SMARCB1 and STK38L, were also functionally scrutinized, providing evidence of Microsatellite instability (MSI) leads to accumulation of an a tumorigenic role, for SMARCB1 mutations in particular. excessive number of mutations in the genome, mostly small insertions and deletions. MSI colorectal cancers (CRCs), however, Keywords cancer genetics; colorectal cancer; microsatellite instability also contain more point mutations than microsatellite-stable Subject Categories Cancer; Chromatin, Epigenetics, Genomics & Functional (MSS) tumors, yet they have not been as comprehensively stud- Genomics; Systems Medicine ied.
    [Show full text]